Last reviewed · How we verify
GSK2646264 0.5% topical cream
GSK2646264 0.5% topical cream is a Small molecule drug developed by GlaxoSmithKline. It is currently in Phase 1 development.
At a glance
| Generic name | GSK2646264 0.5% topical cream |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GSK2646264 0.5% topical cream CI brief — competitive landscape report
- GSK2646264 0.5% topical cream updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about GSK2646264 0.5% topical cream
What is GSK2646264 0.5% topical cream?
GSK2646264 0.5% topical cream is a Small molecule drug developed by GlaxoSmithKline.
Who makes GSK2646264 0.5% topical cream?
GSK2646264 0.5% topical cream is developed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).
What development phase is GSK2646264 0.5% topical cream in?
GSK2646264 0.5% topical cream is in Phase 1.
Related
- Manufacturer: GlaxoSmithKline — full pipeline
- Compare: GSK2646264 0.5% topical cream vs similar drugs
- Pricing: GSK2646264 0.5% topical cream cost, discount & access